Tyra Biosciences, Inc. (TYRA): Price and Financial Metrics
TYRA Price/Volume Stats
| Current price | $10.22 | 52-week high | $29.60 |
| Prev. close | $10.43 | 52-week low | $6.42 |
| Day low | $9.95 | Volume | 324,600 |
| Day high | $10.68 | Avg. volume | 317,335 |
| 50-day MA | $9.55 | Dividend yield | N/A |
| 200-day MA | $14.76 | Market Cap | 542.58M |
TYRA Stock Price Chart Interactive Chart >
Tyra Biosciences, Inc. (TYRA) Company Bio
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2-related cancers, FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.
TYRA Price Returns
| 1-mo | 2.30% |
| 3-mo | -6.07% |
| 6-mo | -29.61% |
| 1-year | -47.43% |
| 3-year | 94.30% |
| 5-year | N/A |
| YTD | -26.47% |
| 2024 | 0.36% |
| 2023 | 82.24% |
| 2022 | -45.98% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...